Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

[1,5]-Hydride Shift-Cyclization versus C(sp 2 )-H Functionalization in the Knoevenagel-Cyclization Domino Reactions of 1,4- and 1,5-Benzoxazepines.

Tytuł:
[1,5]-Hydride Shift-Cyclization versus C(sp )-H Functionalization in the Knoevenagel-Cyclization Domino Reactions of 1,4- and 1,5-Benzoxazepines.
Autorzy:
Szalóki Vargáné D; Department of Organic Chemistry, University of Debrecen, Debrecen, P. O. Box 400, Debrecen 4002, Hungary.; Doctoral School of Chemistry, University of Debrecen, Egyetem tér 1, Debrecen 4032, Hungary.
Tóth L; Department of Organic Chemistry, University of Debrecen, Debrecen, P. O. Box 400, Debrecen 4002, Hungary.; Department of Organic Chemistry, Semmelweis University, Budapest 1094, Hungary.
Buglyó B; Department of Organic Chemistry, University of Debrecen, Debrecen, P. O. Box 400, Debrecen 4002, Hungary.
Kiss-Szikszai A; Department of Organic Chemistry, University of Debrecen, Debrecen, P. O. Box 400, Debrecen 4002, Hungary.
Mándi A; Department of Organic Chemistry, University of Debrecen, Debrecen, P. O. Box 400, Debrecen 4002, Hungary.
Mátyus P; Institute of Digital Health Sciences, Faculty of Health and Public Services, Semmelweis University, Ferenc tér 15, Budapest 1094, Hungary.
Antus S; Department of Organic Chemistry, University of Debrecen, Debrecen, P. O. Box 400, Debrecen 4002, Hungary.
Chen Y; Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Li D; Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Tao L; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhang Jiang Hi-Tech Park, Shanghai 201203, China.
Zhang H; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhang Jiang Hi-Tech Park, Shanghai 201203, China.
Kurtán T; Department of Organic Chemistry, University of Debrecen, Debrecen, P. O. Box 400, Debrecen 4002, Hungary.
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2020 Mar 11; Vol. 25 (6). Date of Electronic Publication: 2020 Mar 11.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, c1995-
MeSH Terms:
Acetylcholinesterase/*metabolism
Cholinesterase Inhibitors/*chemical synthesis
Dibenzoxazepines/*chemical synthesis
Neuroprotective Agents/*chemical synthesis
Acetylcholinesterase/isolation & purification ; Acridines/chemistry ; Animals ; Catalysis ; Cerebral Cortex/chemistry ; Cerebral Cortex/enzymology ; Cholinesterase Inhibitors/pharmacology ; Cyclization ; Density Functional Theory ; Dibenzoxazepines/pharmacology ; Kinetics ; Molecular Structure ; Neuroprotective Agents/pharmacology ; Rats ; Rats, Sprague-Dawley ; Stereoisomerism
References:
J Med Chem. 2010 Oct 14;53(19):7011-20. (PMID: 20806939)
Angew Chem Int Ed Engl. 2011 Apr 4;50(15):3362-74. (PMID: 21413105)
J Neurosci Res. 2012 Oct;90(10):1981-8. (PMID: 22714678)
J Nat Prod. 2016 Nov 23;79(11):2814-2823. (PMID: 27808510)
Biochem Pharmacol. 1961 Jul;7:88-95. (PMID: 13726518)
Biochim Biophys Acta. 2014 Aug;1842(8):1240-7. (PMID: 24189435)
Anal Bioanal Chem. 2015 Feb;407(6):1567-76. (PMID: 25542582)
Molecules. 2018 Dec 08;23(12):. (PMID: 30544832)
Acta Pharmacol Sin. 2021 Jan;42(1):36-44. (PMID: 32393798)
Angew Chem Int Ed Engl. 2008;47(45):8670-3. (PMID: 18846524)
Chemistry. 2013 Sep 27;19(40):13274-87. (PMID: 24027042)
J Med Chem. 1996 Aug 30;39(18):3539-46. (PMID: 8784452)
J Med Chem. 1994 Feb 18;37(4):519-25. (PMID: 7907148)
Beilstein J Org Chem. 2014 Nov 06;10:2594-602. (PMID: 25550721)
Curr Drug Metab. 2017;18(2):96-111. (PMID: 27890007)
Beilstein J Org Chem. 2016 Nov 24;12:2523-2534. (PMID: 28144321)
J Am Chem Soc. 2011 Apr 27;133(16):6166-9. (PMID: 21466211)
Org Biomol Chem. 2012 Dec 21;10(47):9501-6. (PMID: 23111956)
J Org Chem. 2010 Feb 5;75(3):666-79. (PMID: 20030300)
Org Lett. 2013 Apr 19;15(8):1794-7. (PMID: 23540601)
Dalton Trans. 2015 Apr 28;44(16):7634-42. (PMID: 25811701)
J Med Chem. 1974 Jan;17(1):57-62. (PMID: 4808470)
Org Biomol Chem. 2020 Mar 18;18(11):2148-2162. (PMID: 32134098)
Chem Sci. 2018 Jan 17;9(6):1424-1432. (PMID: 29675189)
J Org Chem. 2016 Jul 1;81(13):5775-81. (PMID: 27267801)
Drugs. 2000 Nov;60(5):1095-122. (PMID: 11129124)
Chemistry. 2015 Oct 12;21(42):14678-93. (PMID: 26239615)
Angew Chem Int Ed Engl. 2014 May 12;53(20):5010-36. (PMID: 24706531)
J Am Chem Soc. 2010 Sep 1;132(34):11847-9. (PMID: 20701277)
Eur J Med Chem. 2017 Sep 29;138:738-747. (PMID: 28728106)
J Org Chem. 2010 Feb 5;75(3):627-36. (PMID: 20039606)
J Am Chem Soc. 2012 May 2;134(17):7384-91. (PMID: 22480322)
J Org Chem. 2014 Aug 15;79(16):7451-8. (PMID: 25068595)
Chirality. 2010 Feb;22(2):229-33. (PMID: 19408332)
J Am Chem Soc. 2012 Oct 17;134(41):16991-4. (PMID: 23030547)
J Nat Prod. 2013 Apr 26;76(4):745-9. (PMID: 23421714)
Angew Chem Int Ed Engl. 2012 Nov 5;51(45):11311-5. (PMID: 23042555)
Nat Prod Rep. 2019 Jun 19;36(6):889-918. (PMID: 31139804)
J Med Chem. 1992 May 15;35(10):1887-97. (PMID: 1375293)
Chemistry. 2012 Jul 16;18(29):8891-5. (PMID: 22706891)
Nature. 2012 Feb 29;483(7387):70-3. (PMID: 22382981)
Org Lett. 2011 Feb 18;13(4):600-3. (PMID: 21218793)
J Med Chem. 1989 Sep;32(9):2058-62. (PMID: 2769679)
ACS Chem Biol. 2013 Aug 16;8(8):1841-51. (PMID: 23738709)
Bioorg Med Chem Lett. 2015 Jan 1;25(1):48-52. (PMID: 25435147)
Grant Information:
K-112951, K-120181 Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; GINOP-2.3.2-15-2016-00008 European Regional Development Fund; ÚNKP-19-4 New National Excellence Program of the Ministry for Innovation and Technology
Contributed Indexing:
Keywords: 1,4-benzoxazepine; 1,5-benzoxazepine; TDDFT-ECD calculation; acetylcholinesterase inhibitory activity; domino Knoevenagel-[1,5]-hydride shift-cyclization
Substance Nomenclature:
0 (Acridines)
0 (Cholinesterase Inhibitors)
0 (Dibenzoxazepines)
0 (Neuroprotective Agents)
92-81-9 (acridan)
EC 3.1.1.7 (Acetylcholinesterase)
Entry Date(s):
Date Created: 20200315 Date Completed: 20201221 Latest Revision: 20240328
Update Code:
20240329
PubMed Central ID:
PMC7144003
DOI:
10.3390/molecules25061265
PMID:
32168821
Czasopismo naukowe
Domino cyclization reactions of N -aryl-1,4- and 1,5-benzoxazepine derivatives involving [1,5]-hydride shift or C(sp 2 )-H functionalization were investigated. Neuroprotective and acetylcholinesterase activities of the products were studied. Domino Knoevenagel-[1,5]-hydride shift-cyclization reaction of N -aryl-1,4-benzoxazepine derivatives with 1,3-dicarbonyl reagents having active methylene group afforded the 1,2,8,9-tetrahydro-7b H -quinolino [1,2- d ][1,4]benzoxazepine scaffold with different substitution pattern. The C(sp 3 )-H activation step of the tertiary amine moiety occurred with complete regioselectivity and the 6- endo cyclization took place in a complete diastereoselective manner. In two cases, the enantiomers of the chiral condensed new 1,4-benzoxazepine systems were separated by chiral HPLC, HPLC-ECD spectra were recorded, and absolute configurations were determined by time-dependent density functional theory- electronic circular dichroism (TDDFT-ECD) calculations. In contrast, the analogue reaction of the regioisomeric N -aryl-1,5-benzoxazepine derivative did not follow the above mechanism but instead the Knoevenagel intermediate reacted in an S E Ar reaction [C(sp 2 )-H functionalization] resulting in a condensed acridane derivative. The AChE inhibitory assays of the new derivatives revealed that the acridane derivative had a 6.98 μM IC 50 value.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies